Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 30

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Comparison of peripapillary and perimacular flow density of POAG eyes with normal IOP under Tafluprost therapy compared with post-surgery eyes

Hannah Weindler; Martin Stephan Spitzer; Maximilian Schultheiß; Robert Kromer

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1025. doi:

ARVO Annual Meeting Abstract July 2018

DNA Nanoparticles for the Treatment of Retinal Diseases: in-vivo results

Sven Schnichels; David Simmang; Lisa Strudel; Jose Hurst; Jan Willem de Vries; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5683. doi:

ARVO Annual Meeting Abstract July 2018

Lipid DNA Nanoparticles – a versatile vehicle for anterior segment drug delivery

Lisa Strudel; Jose Hurst; Jan Willem de Vries; Agnieszka Gruszka; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5684. doi:

ARVO Annual Meeting Abstract July 2018

Hyaluronic acid based cross-linked hydrogels – a biosafe, sufficient tamponade of the vitreous body

Lisa Katharina Pohl; Kai Januschowski; Sven Schnichels; Jose Hurst; Christine Hohenadl; Charlotte Reither; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5931. doi:

ARVO Annual Meeting Abstract June 2017

Measurement of SD-OCT Bruch’s Membrane Opening Minimum Rim Width: Method to correct for Optic Nerve Circumference

Robert Kromer; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1310. doi:

ARVO Annual Meeting Abstract June 2017

SD-OCT imaging of retinal degeneration in juvenile CLN3 disease - a potential adjunctive tool for global neurodegenerative assessment

Simon Dulz; Yevgenija Atiskova; Jan-Niklas Hochstein; Lars Wagenfeld; Miriam Nickel; Jan Sedlacik; Christoph Schwering; Martin Stephan Spitzer; Alfried Kohlschütter; Angela Schulz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1316. doi:

ARVO Annual Meeting Abstract June 2017

Establishment Of A Porcine Corneal Endothelial Organ Culture Model

Maximilian Schultheiss; Berenike Kunzmann; Christian Klameth; Karl-Ulrich Bartz-Schmidt; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1464. doi:

ARVO Annual Meeting Abstract June 2017

Travoprost loaded lipid DNA-nanoparticles as a new and improved treatment for glaucoma

Sven Schnichels; Jan Willem de Vries; Agnieszka Gruszka; Karl Ulrich Bartz-Schmidt; Sascha Dammeier; Andreas Herrmann; Martin Stephan Spitzer; Jose Hurst

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4105. doi:

ARVO Annual Meeting Abstract June 2017

Lipid modified aptamers as vehicles for ophthalmic drug delivery

Lisa Strudel; Jose Hurst; Agnieszka Gruszka; Ullrich Hagel; Jan Willem de Vries; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4107. doi:

ARVO Annual Meeting Abstract June 2017

Efficacy of two different thiol-modified crosslinked hyaluronate formulations compared to silicone oil in a model of retinal detachment

Martin Stephan Spitzer; Nele Schneider; Jose Hurst; Christine Hohenadl; Kai Januschowski; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4174. doi:

ARVO Annual Meeting Abstract June 2017

Picosecond infrared laser - fibre-assisted-sclerostomy (PIRL-FAST): A first proof of principle analysis

Juliane Mehlan; Stephanie Uschold; Nils- Owe Hansen; Tobias Gosau; Dennis Eggert; Martin Stephan Spitzer; Hannes Petersen; Udo Schumacher; Stephan Johannes Linke; Dwayne Miller

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4990. doi:

ARVO Annual Meeting Abstract September 2016

Hypothermia protects retinal ganglion cells from cell death in an organotypic ischemia model

Jose Hurst; Patricia Klemm; Matthias Blak; Thoralf Herrmann; Max Schultheiss; Karl-Ulrich Bartz-Schmidt; Guenther Zeck; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4414. doi:

ARVO Annual Meeting Abstract September 2016

Novel thixotropic silicone oils – the ketchup bottle approach for trocar-guided vitrectomy

Christian Klameth; Christian Lingenfelder; Christoph Lindner; Berenike Kunzmann; Kai Januschowski; Karl-Ulrich Bartz-Schmidt; Max Schultheiss; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4477. doi:

ARVO Annual Meeting Abstract September 2016

In-vitro and in-vivo toxicological evaluation of alkyl-modified DNA nanoparticles

Katharina Froessl; Jan Willem De Vries; Johanna Wude; Jose Hurst; Agnieszka Gruszka; Karl-Ulrich Bartz-Schmidt; Andreas Hermann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5054. doi:

ARVO Annual Meeting Abstract September 2016

Kanamycin loaded lipid modified DNA-Nanoparticles with superior bacterial growth inhibition

Lisa Strudel; Jose Hurst; Jan Willem De Vries; Agnieszka Gruszka; Karl-Ulrich Bartz-Schmidt; Andreas Hermann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5055. doi:

ARVO Annual Meeting Abstract September 2016

Intravenous fibrinolysis in acute non-arteritic central retinal artery occlusion - revisited

Martin Stephan Spitzer; Sven Poli; Florian Haertig; Nicolas Feltgen; Max Schultheiss

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5352. doi:

ARVO Annual Meeting Abstract June 2015

Quantitative comparison and toxicological evaluation of DNA-based nanoparticles for the treatment of anterior eye segment diseases

Jan Willem De Vries; Martin Stephan Spitzer; Agnieszka Gruszka; Aileen Breitschwerdt; Patricia Deissenroth; Johanna Hofmann; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1538. doi:

ARVO Annual Meeting Abstract June 2015

Efficacy & functionality of antibiotic delivery through DNA based nanoparticles

Sven Schnichels; Martin Stephan Spitzer; Lisa Strudel; Jose Hurst; Agnieszka Gruszka; Patricia Deissenroth; Sascha Dammeier; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Jan Willem De Vries

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1539. doi:

ARVO Annual Meeting Abstract June 2015

An ex-vivo model for the short term IOP development for vitreous tamponades

Kai Januschowski; Siegfried Mariacher; Martina Ebner; sven schnichels; jose hurst; Peter Szurman; Karl Ulrich Bartz-Schmidt; Martin Stephan Spitzer; Johanna Hofmann, Lisa Pohl, Nele Schneider,

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):211. doi:

ARVO Annual Meeting Abstract June 2015

Hydrophilic vitreous substitute based on cross- linked hyaluronate - assessment of effects on retinal function and intraocular pressure using alternatives to animal testing

Lisa Pohl; Kai Januschowski; Sven Schnichels; Jose Hurst; Martin Prinz; Christine Hohenadl; Charlotte Reither; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5732. doi:

1 2

Next 20 Results »

Advertisement